These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3438152)

  • 1. The use of ciprofloxacin in the treatment of patients with cystic fibrosis.
    van den Broek PJ; Bakker W; Mattie H; van Gulpen C
    Pharm Weekbl Sci; 1987 Dec; 9 Suppl():S68-71. PubMed ID: 3438152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized study of two dosage regimens of ciprofloxacin for treating chronic bronchopulmonary infection in patients with cystic fibrosis.
    Shalit I; Stutman HR; Marks MI; Chartrand SA; Hilman BC
    Am J Med; 1987 Apr; 82(4A):189-95. PubMed ID: 3555035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential ciprofloxacin therapy in pediatric cystic fibrosis: comparative study vs. ceftazidime/tobramycin in the treatment of acute pulmonary exacerbations. The Cystic Fibrosis Study Group.
    Church DA; Kanga JF; Kuhn RJ; Rubio TT; Spohn WA; Stevens JC; Painter BG; Thurberg BE; Haverstock DC; Perroncel RY; Echols RM
    Pediatr Infect Dis J; 1997 Jan; 16(1):97-105; discussion 123-6. PubMed ID: 9002118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-vitro investigation of the antibacterial activity of agents which may be used for the oral treatment of lung infections in CF patients.
    Richards RM; Hamilton VE; Thomas MR
    J Antimicrob Chemother; 1998 Aug; 42(2):171-8. PubMed ID: 9738834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of serious infections with intravenous ciprofloxacin.
    Scully BE; Neu HC
    Am J Med; 1987 Apr; 82(4A):369-75. PubMed ID: 3555062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluoroquinolones in the treatment of cystic fibrosis.
    Høiby N; Pedersen SS; Jensen T; Valerius NH; Koch C
    Drugs; 1993; 45 Suppl 3():98-101. PubMed ID: 7689459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergent resistance to ciprofloxacin amongst Pseudomonas aeruginosa and Staphylococcus aureus: clinical significance and therapeutic approaches.
    Ball P
    J Antimicrob Chemother; 1990 Dec; 26 Suppl F():165-79. PubMed ID: 2127272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of ciprofloxacin in patients with cystic fibrosis.
    Bosso JA; Black PG
    Drug Intell Clin Pharm; 1988; 22(7-8):551-3. PubMed ID: 3416737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antibiotic treatment of cystic fibrosis exacerbations].
    Dumcius S
    Medicina (Kaunas); 2003; 39(3):221-4. PubMed ID: 12695633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suboptimal ciprofloxacin dosing as a potential cause of decreased Pseudomonas aeruginosa susceptibility in children with cystic fibrosis.
    Guillot E; Sermet I; Ferroni A; Chhun S; Pons G; Zahar JR; Jullien V
    Pharmacotherapy; 2010 Dec; 30(12):1252-8. PubMed ID: 21114393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibacterial therapy in cystic fibrosis.
    Mouton JW; Kerrebijn KF
    Med Clin North Am; 1990 May; 74(3):837-50. PubMed ID: 2186247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacterial infection in cystic fibrosis.
    May JR; Herrick NC; Thompson D
    Arch Dis Child; 1972 Dec; 47(256):908-13. PubMed ID: 4630478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term persistence of ciprofloxacin-resistant Haemophilus influenzae in patients with cystic fibrosis.
    Campos J; Román F; Georgiou M; García C; Gómez-Lus R; Cantón R; Escobar H; Baquero F
    J Infect Dis; 1996 Dec; 174(6):1345-7. PubMed ID: 8940231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ciprofloxacin in the treatment of Pseudomonas infection in cystic fibrosis patients.
    Rubio TT; Shapiro C
    J Antimicrob Chemother; 1986 Nov; 18 Suppl D():147-52. PubMed ID: 3100490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tobramycin therapy of pulmonary infections in patients with cystic fibrosis.
    Hawley HB; Lewis RM; Swartz DR; Gump DW
    Curr Ther Res Clin Exp; 1974 May; 16(5):414-23. PubMed ID: 4209057
    [No Abstract]   [Full Text] [Related]  

  • 16. Antibacterial therapy in cystic fibrosis. A review of the literature published between 1980 and February 1987.
    Michel BC
    Chest; 1988 Aug; 94(2 Suppl):129S-140S. PubMed ID: 3293939
    [No Abstract]   [Full Text] [Related]  

  • 17. Oral ciprofloxacin therapy of infections due to Pseudomonas aeruginosa.
    Scully BE; Neu HC; Parry MF; Mandell W
    Lancet; 1986 Apr; 1(8485):819-22. PubMed ID: 2870313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ciprofloxacin monotherapy for acute pulmonary exacerbations of cystic fibrosis.
    Goldfarb J; Stern RC; Reed MD; Yamashita TS; Myers CM; Blumer JL
    Am J Med; 1987 Apr; 82(4A):174-9. PubMed ID: 3555032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of ciprofloxacin in children with cystic fibrosis.
    Orenstein DM; Pattishall EN; Noyes BE; Kurland G; Hartigan ER; Yu VL
    Clin Pediatr (Phila); 1993 Aug; 32(8):504-6. PubMed ID: 8403750
    [No Abstract]   [Full Text] [Related]  

  • 20. Hemophilus influenzae, Staphylococcus aureus, Pseudomonas cepacia, and Pseudomonas aeruginosa in patients with cystic fibrosis.
    Høiby N
    Chest; 1988 Aug; 94(2 Suppl):97S-103S. PubMed ID: 3293941
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.